Loss of height greater than 1.5 inches is listed as a factor indicating BMD testing.

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Prepare for the CMS II Rheumatology E1 Exam with our comprehensive quiz. Study using flashcards and multiple-choice questions, each with hints and explanations. Get ready for success!

Multiple Choice

Loss of height greater than 1.5 inches is listed as a factor indicating BMD testing.

Explanation:
Height loss signals potential vertebral changes from osteoporosis, so a height loss exceeding about 1.5 inches is used as a trigger to perform bone mineral density testing. This threshold strikes a balance between catching meaningful vertebral changes and avoiding over-testing. DXA-based BMD testing confirms bone density and helps guide treatment decisions to prevent future fractures. Smaller losses (0.5 inch) can miss cases, while larger losses (2–3 inches) are less consistently used as screening criteria in standard guidelines, making the 1.5-inch cutoff the most appropriate cue for testing.

Height loss signals potential vertebral changes from osteoporosis, so a height loss exceeding about 1.5 inches is used as a trigger to perform bone mineral density testing. This threshold strikes a balance between catching meaningful vertebral changes and avoiding over-testing. DXA-based BMD testing confirms bone density and helps guide treatment decisions to prevent future fractures. Smaller losses (0.5 inch) can miss cases, while larger losses (2–3 inches) are less consistently used as screening criteria in standard guidelines, making the 1.5-inch cutoff the most appropriate cue for testing.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy